On October 11, 2023, Capital Square announced the full-cycle sale of the Kinston, North Carolina medical building held by CS1031 Kinston MOB, DST. Bio-Medical Applications, a Fresenius company, was the building's tenant.
Capital Square reported the result to investors as follows:
Metric | Figure |
|---|---|
Total return | 147.63%, as reported by the sponsor (announcement) |
Annualized return | 7.15%, as reported by the sponsor (announcement) |
The trust first filed its Form D on November 3, 2016, a 506(b) offering with a $2.462 million equity ceiling and a $25,000 minimum investment. Measured from that first filing to the sale, the hold ran 6.9 years.
The announcement gives the return, not the sale price. The disposition value is not stated, and the Form D on record carries the offering's size rather than its result.
By Top1031's count, the sale is the 52nd Capital Square offering to reach full cycle.